Organization · Type 2 NPI
ST Paul Place Specialists, Inc.
Hematology & Oncology Physician · Baltimore, MD
Practice location
227 Saint Paul Place, 4th Floor
Baltimore, MD 21202-2001
Fax (410) 783-5864
Mailing address
PO Box 824173
Philadelphia, PA 19182-4173
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Hematology & Oncology Physician Primary | 207RH0003X | None listed |
| Medical Oncology Physician | 207RX0202X | None listed |
| Nurse Practitioner | 363L00000X | None listed |
Hematology & Oncology Physician: An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.
Another provider at this address
Other hematology & oncology physician providers in Baltimore
- Lutherville Hematology and OncologyHematology & Oncology Physician Baltimore, MD NPI 1033958483
- Greater Baltimore Medical Center, Inc.Hematology & Oncology Physician Baltimore, MD NPI 1083436158
- Kenneth Miller MD LLCHematology & Oncology Physician Baltimore, MD NPI 1114233012
- Greater Baltimore Medical Center, Inc.Hematology & Oncology Physician Baltimore, MD NPI 1114749207
- Myo Thant M.d.p.a.Hematology & Oncology Physician Baltimore, MD NPI 1215003637
- University of Maryland Oncology Associates, PAHematology & Oncology Physician Baltimore, MD NPI 1245047612
- Union Memorial HospitalHematology & Oncology Physician Baltimore, MD NPI 1356571939
- Krishnan Hematology Oncology Associates LLCHematology & Oncology Physician Baltimore, MD NPI 1376877621
About NPI 1174564736
ST Paul Place Specialists, Inc.'s National Provider Identifier is 1174564736, issued on Jun 8, 2006. The primary taxonomy on file is Hematology & Oncology Physician (207RH0003X), and the practice location is in Baltimore, MD. The record was last updated on Dec 18, 2024.